E Tender For Procurement Of Kits , Chemicals And Reagents For Two Years From The Date Of Award Of Contract ( Aoc ) And Its Extension , If Required

Tender Notice

28163066
Corrigendum : E Tender For Procurement Of Kits , Chemicals And Reagents For Two Years From The Date Of Award Of Contract ( Aoc ) And Its Extension , If Required
Indian
West Bengal
13-07-2021
16-07-2021
16-07-2021

Tender Details

E Tender For Procurement Of Kits , Chemicals And Reagents For Two Years From The Date Of Award Of Contract ( Aoc ) And Its Extension , If Required-1 Acetone 2 Albumin - Test Kit 3 Alkaline Phosphatase - Test Kit 4 Amylase - Test Kit 5 Antiseptic Lotion 15% Cetrimide W / V + Chlorhexidine Gluconate Soln. I.P. 7.5% V / V ( Container Of 5 Litres ) 6 Aso Latex Agglutination Kit 7 Bivalent Antigen-Detecting Rapid Diagnostic Tests ( Rdts ) For P. Falciparum And P. Vivax Malaria Undr In Freezing 8 Brain Heart Infusion Agar 9 Brain Heart Infusion Broth 10 Benedict Solution 11 Calcium Reagent Test Kit 12 Cedarwood Oil 30 Ml 13 Cholesterol - Test Kit 14 Cpk ( Mb ) Test Kit 15 C-Reactive Protein ( Immunoterbedimetric ) - Test Kit 16 Creatinine -Test Kit 17 Cresol With Soap Solution 50% I.P. 18 Dengue Igm Capture Elisa Kit 19 Dengue Ns1 Antigen Detection Kit ( Elisa ) 20 Disinfectant Fluids ( Black ) , Phenolic Type, Grade 3 ( Rw Coeff 5-7 ) Is 1061:1997 21 Giemsa Stain 25 Mg. 22 Gluteraldehyde Solution 2% For Instrument Sterilisation 23 Hand Disinfactant : Each 100 Gm Soln. Contains : 2- Propanol- 45G, 1-Propanol- 30G, Ethyl-Hexadecyl- Dimethyl - Ammonium Ethyl Sulphate - 0.2 G 24 Hand Rub Soln.: 0.5% W / V Chlorhexidine Gluconate & 70 % V / V Ethanol 25 Hbsag ( Elisa ) Kit. 26 Hbsag ( Rapid ) Kit. 27 Hcv ( Elisa ) Kit \ 28 Hcv ( Rapid ) Kit 29 Hdl Cholesterol - D ( Immunoterbedimetric ) Test Kit 30 Hiv ( Elisa ) Kit \ 31 Hiv ( Rapid ) Testing Kits. 32 Immersion Oil 33 Isoprophyl Alcohol Ip 70% V / V 34 Kit For Early Diagnosis Of Pregnancy By Immunological Method ( Hcg ) 35 Ldl Direct Diagnostic Kit 36 Leishman Stain Soln. 37 Lipase Test Kit 38 Mac Conkey Agar 39 Mueller Hintone Agar 40 Multistrips- 8 Parameter ( Alb, Glucose, Ph, Ketone, Blood, Bilirubin, Urobilinogen & Nitrite ) 41 Paraffin Wax 58 C To 60 C 42 Paraffin Wax 60 C X 62 C 43 Peptone 44 Rpr ( Rapid Plasma Reagin ) Kit 45 Sgot Test Kit 46 Sgpt Test Kit 47 Simmons Citrate Agar 48 Sodium Hypochloride – 500 Ml Bot. 49 Surface Disinfactant Soln ( Each 100 Gm Contains: 1, 6 Di-Hydroxy 2, 5 Di-Oxyhexane ( Chemically Bound Formaldehyde ) - 11.2 Gms , Glutaraldehide 5 Gm , Benzalkonium Chloride 5 Gm, Alkyl Urea Derivatives 3 Gms 50 Tcbs Agar 51 Total Protein Test Kit 52 Treponemal 53 Triglyceride Test Kit 54 Tsh - Elisa 55 Tsi Agar 56 Typhoid Igm Test Kit 57 Urea - ( Gldh ) Reagent Kit 58 Urea - ( Berthelot ) Reagent Kit 59 Urea Agar Base 60 Uric Acid Test Kit 61 Uristix ( 10 Parameters ) 62 Widal Antigen Test Kit 63 Xld Agar 64 Xylene 65 Whole Blood Finger Prick Hbv Card Test Kit For Detection Of Hbsag Be For 50 Tests. \ N7 ) Shelf Life- Minimum 18 Months From Manufacture

Corrigendum Details

Sr No CorrigendumDate Corrignedum CorrigendumType NewSubmissionDate
1 25-Jun-2021 CORRIGENDUM Other 05-07-2021
2 02-Jul-2021 CORRIGENDUM-2 Date 16-07-2021
3 05-Jul-2021 CORRIGENDUM-3 Other 16-07-2021
4 13-Jul-2021 CORRIGENDUM-4 Other 16-07-2021

Key Value

Document Fees
Refer document
EMD
INR 100000.00 /-
Tender Value
Refer document

BOQ Items

Name of Work: E TENDER FOR PROCUREMENT OF KITS, CHEMICALS & REAGENTS FOR TWO YEARS FROM THE DATE OF AWARD OF CONTRACT (AOC) AND ITS EXTENSION, IF REQUIRED
Sl. No. Group - I Cat. No. Tentative annual requirment (as per Accounting Unit) Accounting Unit
1 1 Acetone A02/KCR 2500 Bot. of 500 ml
2 2 Albumin - Test Kit A06/KCR 200000 1 ml
3 3 Alkaline Phosphatase - Test Kit A07/KCR 200000 1 ml
4 4 Amylase - Test kit A16/KCR 50000 1 ml
5 5 Antiseptic Lotion 15% Cetrimide w/v + Chlorhexidine Gluconate Soln. I.P. 7.5% v/v (Container of 5 litres) A29/KCR 17000 Container of 5 litres
6 6 ASO LATEX AGGLUTINATION KIT A31/KCR 250 100 Test
7 7 BIVALENT ANTIGEN-DETECTING RAPID DIAGNOSTIC TESTS (RDTs) FOR P. FALCIPARUM AND P. VIVAX MALARIA UNDR NVBDCP\nTECHNICAL SPECIFICATIONS: -\nA. Description of the Test Kit:\nThe Bivalent Rapid Diagnostic Test (RDT) for Malaria should comprise of test card (cassette) and reagents including buffer solution in a dropping bottle. \n The test kit should be able to rapidly diagnose both P. Falciparum and P. Vivax. The test should be based on the principle of capture of parasite antigen from blood using monoclonal antibodies specific for antigen targets. \n Each test kit should contain all the materials required for performing the test including individually packed sterile lancets for pricking, heparinised capillary tubes (diameter-1mm) with relevant markings and reaction tubes with stand /wells as required. \n The manufacturer should have specified International Organisation for Standardization (ISO) certification. One should be able to perform the test with the blood taken by finger prick of the patient. \n Temperature stability data: information on thermal stability data for the lab product should be available. \nTYPE OF RDT- The RDT should be able to detect P. Falcciparaum Histidine –Rich Protein – 2 (HRP2) and P. Vivax Lactate Dehyydrogenase (pLDH) and not aldolase. \nRDT Performance Criteria :- \n The products should conform to the following set of criteria (A-D), based on the results of the evaluation of the WHO Malaria RDT Product Testing. \nA. For the detection of Plasmodium falciparum (Pf) in all transmission settings the panel detection score (PDS) against Pf samples should be at least 75% at 200 parasites/uL. \nB. For the detection of Plasmodium Vivax (Pv) in all transmission settings the panel detection score (PDS) against Pv samples should be at least 75% at 200 parasites /uL. \nC. The false positive rate should be less than 10% .\nD. The invalid rate should be less than 5%.\nEach lot of RDT should be tested at a designed lot testing laboratory by using WHO protocol at the time of delivery. Only those lots with PASS report will be accepted for delivery. \nContent of Kit and Packaging: \nEach kit should be hermetically sealed in non-permeable pouch and should have moisture absorbent material. 10 such test cards (cassette), or lesser quantity as required by the programme should be packed in a box containing the reagents and the test plates. \nAdequate literature detailing the test kit components, principle , methodologies and validity criteria as specified under ‘RDT performance criteria’ should be provided in the kit inserts with the test kits. \nStorage conditions, expiry dates and limitations of test should be provided. The small box should be packed in bigger cardboard carton containing 5 such small boxes. The carton should be sealed with a sealing tape. \n C. Shelf Life :\n Shelf life from manufacturing date to expiry date should be at least 2 years and the RDTs should not have lost more than 1/6th of their effective life from the date at the time the material is offered for inspection .Losses due to premature deterioration as a result of biological and other activities during the life of potency of the Rapid Diagnostic Tests will be made good by the firm at its own cost. \nD. Stability requirements at temperatures of intended storage, transport and use : \n RDTs should have high thermal stability for use in areas with very high ambient temperatures as per the evaluation by WHO Malaria RDT Product Testing against a single cultured P. falciparum isolate at 200 parasites /uL at based line and after 60 days of incubation at room temperature, 35°C and 45° C. \nE. Quality Assurance :- \n The product should comply with ISO 13485.\nF. Marking /Labelling: \ni. Each card (cassette) should have space for recording particulars of patients, time and date of the test. \nii. The large carton (containing 10 small boxes) and small box (containing 10 tests) should have the following markings: \na. Name of the Test \nb. Lot number\nc. Manufacturing and expiry date\nd. Name of the manufacturer with address\ne. Details of the contents\nf. Storage conditions. \ng. Handling procedures\nh. Disposal instruction for the box and its contents \ni. GOI,NVBDCP Supply –NOT FOR SALE \nG. Details regarding approval of license:\ni. Manufacturing and Marketing License for manufacturing of Rapid Malaria Diagnostic Tests should have been obtained from the concerned Regulatory authority in the country by the manufacturer. \nii. The Bidders must submit scientific study report in support of their claim of performance criteria of the offered product, i.e. WHO FIND report mentioning the Panel detection score, false positivity rate, invalid rate, ease of use ,thermal stability data etc. Claim should be supported by reports of actual shelf life studies. \niii. Reports of proven performance of the offered product in conditions similar to Indian field conditions (room temperature up to 40° C) with certification of no adverse report for the offered product from the end users during the last five years must be submitted with the bid. \niv. The Bidders must submit a sample of their product (for example as two kits to procurement Agent for assessment of user friendliness by the Procurement Agent. \nv. Recommended conditions for storage (e.g. room temperature) and shelf life should clearly be mentioned on the label of RDT. \nH. Shipping from manufacturer : \nBefore shipping : The manufacturer should provide to the consignees the details of airway bill numbers, airline carrier, flight number, numbers of containers, expected arrival tiem . These details should be sent by email and flowed up by fax.\nThe shipper (air carrier) should be notified of temperature storage requirements by the manufacturer in writing and by clear markings on cartons and related documents.(Stowage of the shipment close to the skin of some aircraft may result in freezing.) \nThe manufacturer should initiate shipment only when the consignee has confirmed the receipt of shipping notification. \nManufacturer should ensure/arrange to have customs agents or other personnel on site to receive materials. Shipments should be moved immediately to moderate temperature storage places (less than 30° C ) .Leaving materials on airport tarmacs, in customs sheds , or in vehicles should be avoided. \nI. Ground Transportation : \nGround transportation should be carried out during any stage of delivery without delay, maintaining temperature requirements while the vehicle is moving and is parked. Avoid leaving RDTs in vehicles parked in the sun. \n B07/KCR 100 Box of 10 RDT Kits with diluents
8 8 Brain Heart Infusion Agar B11/KCR 50 Bot. of 500 gm
9 9 Brain Heart Infusion Broth B12/KCR 50 Bot. of 500 gm
10 10 Benedict Solution B14/KCR 600 Bottle of 500 ml
11 11 Calcium Reagent Test Kit C01/KCR 42000 Test Per ml
12 12 Cedarwood Oil 30 ml C05/KCR 1750 Bottle of 30 ml
13 13 Cholesterol - Test Kit C31/KCR 140000 1 ml
14 14 CPK (MB) Test Kit C44/KCR 8000 1 ml
15 15 C-Reactive Protein (Immunoterbedimetric) - Test Kit C46/KCR 65000 1 ml
16 16 Creatinine -Test Kit C47/KCR 550000 1 ml
17 17 Cresol with Soap Solution 50% I.P. C48/KCR 85000 Container of 5 litres
18 18 Dengue IgM capture ELISA kit\nTechnical Specification: \n1) The ELISA kit should be designed for qualitative detection of dengue IgM antibodies of all 4 dengue serotypes in human serum.\n2) The kit should be provided with the following materials and reagents:\na. Anti-Human IgM coatedBreak-apart Microwells (12*8=96 wells). Desiccant should be provided for storing the unused Microwells which are to be resealed immediately.\nb. Horseradish peroxidase conjugated monoclonal antibody tracer with preservatives.\nc. Chromogenic substrate in buffer.\nd. Positive Control in the form of positive human serum with preservatives and antibiotics.\ne. Negative control in the form of confirmed negative human serum with preservatives and antibiotics.\nf. Calibrators.\ng. Sample diluents.\nh. Wash buffer.\ni. Stop solution.\n3) The time required for performing the test for detection of dengue IgM,should range between 2-4 hours.\n4) The ELISA kit for detection of dengue IgM should have a sensitivity of >95% and a specificity of >98%.\n5) The kit should be such that, one well is to be consumed for evaluation of each sample (barring the wells used for control).\n6) Test ELISA kit should distinguish between Dengue and other diseases with similar clinical presentation.\n7) The kit should have a shelf-life of at least one year when stored at an ambient temperature of 2ºC - 8ºC.\n8) Transportation should be under cold chain\n9) Test kit should fit in all the commonly available Brand/Make of ELISA reader & washer machine.\n10) The volume of each and every reagents or consumables supplied in a pack (for 96 wells) should be such that, tests can be run at least in twelve occasions by using the 96 wells. \n11) User certificates from the reputed institution. D03/KCR 1400 96 wells per kit
19 19 Dengue NS1 Antigen detection kit (Elisa) D04/KCR 3500 96 test kit
20 20 Disinfectant Fluids (Black), Phenolic Type, Grade 3 (RW coeff 5-7) IS 1061:1997 D06/KCR 110000 Cont. of 5 Litres
21 21 Giemsa Stain 25 mg. G02/KCR 3000 Cont. of 25 Gm
22 22 Gluteraldehyde Solution 2% for Instrument Sterilisation G06/KCR 13000 Cont. of 5 Litres
23 23 Hand Disinfactant : Each 100 gm Soln. contains : 2- Propanol- 45g, 1-Propanol- 30g, Ethyl-Hexadecyl- Dimethyl - Ammonium Ethyl Sulphate - 0.2 g H04/KCR 100000 Bottle of 100 ml
24 24 Hand Rub Soln.: 0.5% W/V Chlorhexidine Gluconate & 70 % v/v Ethanol H05/KCR 85000 Bottle of 500 ml
25 25 HbsAg (Elisa) Kit\nSpecification:\n1. Microplate ELISA coated with monoclonal antibodies to HBsAG.\n2. The assay should be able to detect surface antigen to Hepatitis B virus.\n3. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions limitation of assays, manufacturing & expiry dates should be provided with each kit.\n4. The kit to be procured should have approval of the statutory authority in its country of origin.\n5. In case of imported kits it should have been registered and licensed in India by DCG(I) .\n6. In case of indigenous manufacturers they shall have license issued by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I).\n7. The kit should have minimum shelf life of 60% or 12 months (whichever is more) at the port of discharge of consignees.\n8. The assay component should include reactive and non-reactive controls.\n9. The assay should have sensitivity of more than or equal to 99% and specificity of more than or equal to 98%\n10. The assay should have analytical sensitivity of detecting less than or equal to 0.5ng/ml.\n11. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n12. The Kit size should be 96 tests /kit.\n13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015. H07/KCR 1000 Per Kit
26 26 HBsAg (Rapid) Kit\nSpecification:\n1. Should be solid phase/particle coated with monoclonal antibodies to HBsAg.\n2. The assay should be able to detect surface antigen to Hepatitis B virus.\n3. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provided with each kit.\n4. The kit to be procured should have approval of the statutory authority in its country of origin.\n5. In case of imported kits it should be registered and licensed in India by DCG(I) .\n6. In case of indigenous manufacturers they should be licensed by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I).\n7. The kit should have minimum shelf –life of 60% or 12 months (whichever is more) at the port of discharge of consignees.\n8. The total procedure time shall not be more than 30 minutes.\n9. The assay component should include positive and Negative control in each pack of 50 tests.\n10. The assay should have sensitivity of more than or equal to 99% and specificity of more than or equal to 98%.\n11. The assay should have analytical sensitivity of detecting less than or equal to 0.5ng/ml.\n12. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n13. The pack size should not be more than 50 tests wherein each test in individually packed.\n14. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015. H08/KCR 2000 Per Test
27 27 HCV (Elisa) Kit\nSpecification:\n1. Microplate ELISA Coated with recombinant / synthetic peptide antigens for core, NS3, NS4 and NS5.\n2. Adequated documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays ,manufacturing & expiry dates should be provided with each kit. \n3. The kit to be procured should have approval of the statutory authority in its country of origin.\n4. In case of imported kits it should have been registered and licensed in India by DCG(I).\n5. In case of indigenous manufactures they shall have license issued by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I).\n6. The kits should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees.\n7. The assay component should include reactive and non-reactive controls.\n8. The assay should have a sensitivity more than or equal to 99% and specificity of more than or equal to 98%.\n9. The manufacturer / authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n10. The kit size should be 96 test/.kit. \n11. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015. H09/KCR 2000 Per Kit
28 28 HCV (Rapid) Kit\nSpecification:\n 1. Should be solid phase/particle coated with recombinant and / or synthetic peptide antigens for Core,NS3,NS4 and NS5.\n2. Adequate documents detailing the principle, components, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provide with each kit.\n3. The kit to be procured should have approval of the statutory authority in its country of origin\n4. In case of imported kits it should have been registered and licensed in India by DCG(I).\n5. In case of indigenous manufactures they should be licensed by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centers approved by DCG(I).\n6. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees.\n7. The total procedure time shall not be more than 30 minutes.\n8. The assay component should include positive and Negative control in each pack of 50 tests.\n9. The assay should have sensitivity of more than or equal to 99% and specificity or more than or equal to 98%.\n10. The manufacture / authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n11. The Pack size should not be more than 50 tests wherein each test is individually packed.\n12.The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendations dated 12th January 2015.\n\n H10/KCR 210000 Per Test
29 29 HDL Cholesterol - D (Immunoterbedimetric) Test Kit H11/KCR 10000 1 ml
30 30 HIV (Elisa) Kit\nSpecification:\n1. Should be solid phase microplate Coated HIV I & II Recombinant and/or synthetic peptide antigens.\n2. The assay should detected HIV 1 and II antibodies.\n3. Adequate documents detailing the principal, components, details of antigen for antibody detection of HIV 1and 2, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage condition, limitation of assays, manufacturing & expiry dates should be provide with each kit.\n4.The kit should have approval of the statutory authority in its country of origin.\n5.In case of Imported kits it should be registered and licensed in India by DCG(I)\n6. In case of indigenous manufacturers should be licensed issued by the competent authority defined under Drugs and Cosmetics Act, 1940 & also be evaluated by the centers approved by DCG(I)\n7.The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees .\n8.The assay component should includ reactive and non-reactive controls with each kit.\n9.The assay should have sensitivity level of more than or equal to 99.5% and specificity level of more than or equal to 98%.\n10.The manufacture / authorized agent should ensure maintenance of cold chain during storage and transport the kits at 2°C - 8°C . The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n11. The pack size should be 96 tests/kit.\n12.The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015. H14/KCR 2000 Per Kit
31 31 HIV (Rapid) Testing Kits [By Principal of Enzyme Immuno Assay, Agglutination, or any other Principle]\nSpecification :- \n1. Should be a solid phase coated HIV I & HIV II recombinant and / or synthetic peptide antigens.\n2. The assay should detect HIV I & II antibodies in plasma,serum or whole blood.\n3. Adequte documents detailing the principle , components, details of antigen for antibody detection of HIV I & II, bio-safety, methodologies, validity criteria, interpretation of results, performance characteristics, storage conditions, limitation of assays, manufacturing & expiry dates should be provided with each kit. \n4. The kit should have approval of the statutory authority from the country of origin.\n5. In case of imported kits it should be registered and licensed by DCG(I).\n6. In case of indigenous manufacturers should be licensed by the competent authority defined under Drugs and Cosmetics Act 1940,also be evaluated by the centers approved by DCG(I).\n7. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees.\n8. The time required for performing the test should not be more than 30 minutes.\n9. The control dot/band should be able to detect the presence of human immunoglobulins and should not be just a “procedural control” or meant for merely checking the flow of reagents or integrity of the antigen.\n10. The assay should have sensitivity of more than or equal to 99.5% and specificity of more than or equal to 98%.\n11. The manufacturers should ensure that : \na. The test kit should be packed such that there is a provision to conduct single test at a time;\nb. The assay components should include HIV positive and negative serum control sufficient for conducting 20% of the tests (10% negative and 10% positive controls);and \nc. The pack size of HIV rapid test kits should not be more that 50 tests per kit.\n12. The manufacturer/authorized agent should ensure maintenance of cold chain during storage & transport the kits at 2°C - 8°C. The cumulative time temperature indicator technology used should be pre-qualified by WHO. \n13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015. H15/KCR 500 Per Test
32 32 Immersion Oil I02/KCR 1200 Bottle of 30 ml
33 33 Isoprophyl Alcohol IP 70% v/v I05/KCR 50000 Bottle 500 ml
34 34 KIT FOR EARLY DIAGNOSIS OF PREGNANCY BY IMMUNOLOGICAL METHOD (HCG) K02/KCR 400000 Per Kit
35 35 LDL Direct Diagnostic Kit L03/KCR 1100 1 ml
36 36 Leishman Stain Soln. L04/KCR 6000 Bot. of 500 ml
37 37 Lipase Test Kit L09/KCR 34000 1 ml
38 38 Mac Conkey Agar M01/KCR 100 Bottle of 500 gm
39 39 Mueller Hintone Agar M13/KCR 100 Bot. of 500gm.
40 40 Multistrips- 8 Parameter (Alb,Glucose, pH, Ketone, Blood, Bilirubin, Urobilinogen & Nitrite) M15/KCR 3800 Pack of 100 strips
41 41 Paraffin Wax 58 c to 60 c P01/KCR 800 Bottle of 500 gm
42 42 Paraffin Wax 60 c X 62 c P02/KCR 1250 Bottle of 500 gm
43 43 Peptone P04/KCR 50 Bot. of 500gm.
44 44 RPR (Rapid Plasma Reagin) Kit\nSpecification:\n1. The indigenous RPR (Rapid Plasma Reagin) kits should have been manufactured under manufacturing license issued by the State Licensing Authority under the Drugs and Cosmetics Act. The imported kits should have been imported under import License issued by the DCG(I) under Drugs and Cosmetics Act. \n2. The assay should allow for qualitative and semi quantitative determination of Reagin antibodies in serum or plasma for sero-diagnosis of syphilis based on flocculation principle using non treponemal antigens.\n3. The assay should be suitable to perform with either serum or plasma\n4. The assay should have sensitivity of 85% or more in primary syphilis and a specificity of 93% or more.\n5. The assay should be calibrated to WHO reference serum and the same should be supported by statements in kit insert and certificate from manufacturer. \n6. The test should be able to yield results within 20 minutes.\n7. The pack size of RPR test kit should be less than or equal to 50 tests per kit.\n8. The assay components should include positive and negative serum control sufficient for conducting 20% of the tests (10% negative and 10% positive controls). \n9. The kit should have all essential accessories required for the test such as cards, droppers, applicator etc. in adequate quantities for the number of tests to be performed.\n10. The kit should have minimum shelf-life of 60% or 12 months (whichever is more) at the port of discharge of consignees. \n11. The cumulative time temperature indicator technology used should be pre-qualified by WHO.\n12. Literature, detailing the components, methodologies, validity criteria, performance characteristics, storage conditions, manufacturing and expiry dates should be provided with each kit. \n13. The item should be Up graded from III Generation to IV Generation Test Kit in the light of BTS TRG recommendation dated 12th January 2015.\n R05/KCR 140000 Per tests
45 45 SGOT Test Kit S03/KCR 150000 1 ml
46 46 SGPT Test Kit S04/KCR 180000 1 ml
47 47 Simmons Citrate Agar S05/KCR 50 Bot. of 100 gm
48 48 Sodium Hypochloride – 500 ml Bot. S06/KCR 85000 Bot. of 500ml
49 49 Surface Disinfactant Soln (Each 100 gm Contains: 1,6 Di-Hydroxy 2,5 Di-Oxyhexane (Chemically Bound Formaldehyde ) - 11.2 gms , Glutaraldehide 5 gm , Benzalkonium Chloride 5 gm, Alkyl Urea Derivatives 3 gms S10/KCR 52000 Bot. of 500 ml
50 50 TCBS Agar T02/KCR 100 Bot. of 500 gm
51 51 Total Protein Test Kit T08/KCR 185000 1 ml
52 52 TREPONEMAL-SPECIFIC RAPID (POINT-OF-CARE) DIAGNOSTIC TEST FOR SYPHILIS (POC Test Kit)\nTECHNICAL SPECIFICATION : \no The assay should have solid phase coated with synthetic or recombinant type of Treponema Pallidum antigens.\no The assay may be based on any of the rapid test principles:\no (Immunoconcentration/Dot blot Immunoassay (vertical flow), dip stick and comb assay.\no The assay should quantitatively detect total anti-treponemal antibody (IgG and IgM) in whole blood, serum or plasma for serological diagnosis of syphilis in all stages of infection.\no The assay should have an in-built positive and negative control for testing the validity of the test kits. \no The assay should have reactive and non-reactive controls with each kit in adequate volume (minimum 10% of pack size). \no The kit should have 5/6th of the shelf life or 12 months before expiry (whichever is more) at the item of receipt by the consignee. \no Adequate literature detailing the principle, components, methodologies, validity criteria, bio-safety , performance characteristics, storage conditions, limitation of assay, manufacture and expiry dates and methods of disposal should be provided with each kit. \no The imported rapid kit should have approval of the statutory authority in its country of origin. The imported kits should have been registered and licensed in India by the Central Drugs Standard Control Organisation (CDSCO).\no In case of indigenous manufacturers they should have a valid licence issued by the competent authority defined under Drugs and Cosmetics Act, 1940, after appropriate evaluation by the centres approved by the CDSCO. \no The assay should have sensitivity of 90% or more and specificity of 95% or more and the same should be supported by statements in kit insert and certificate from National Institute of Biological Sciences. \no The assay should be calibrated by WHO reference serum and the same should be supported by statements in kit insert and certificate from the manufacturer. \no The manufacturer should ensure the following:\n>> The test should be packed such that there is a provision to conduct single test at a time. \n>> The pack size of test kits should be in 50 (for peripheral health levels) and 100 tests per kit (for secondary and tertiary health care level) but not more than 100 tests per kit.\no The manufacturer /authorized agent should ensure maintenance of cold chain during storage and transport of kits at 2°C - 8°C.\no Total procedure time should not be more than 30 minutes.\no The test kit should be supplied with micro-pipette of 1 micro litre volume \no The test kit should be supplied with sterilized disposable lancet one for each test\no Alcohol soaked swab should be supplied with one for each test.\n T10/KCR 1000 Per Test
53 53 Triglyceride Test Kit T12/KCR 110000 1 ml
54 54 TSH - Elisa T14/KCR 1750 96 wells per kit
55 55 TSI Agar T15/KCR 50 Bot. of 100 gm
56 56 Typhoid IgM Test Kit T16/KCR 50 30 Test
57 57 Urea - ( GLDH) Reagent Kit U01/KCR 172000 1 ml
58 58 Urea -(Berthelot) Reagent Kit U02/KCR 660000 1 ml
59 59 Urea Agar Base U03/KCR 50 Bot. of 100 gm
60 60 Uric Acid Test Kit U05/KCR 82000 1 ml
61 61 Uristix (10 Parameters) U06/KCR 9750 100 Test Strips/ Box
62 62 Widal Antigen Test Kit W03/KCR 16750 1 ml
63 63 XLD Agar X01/KCR 100 Bot. of 500 gm
64 64 Xylene X02/KCR 1875 Bottle of 500 ml
65 65 Whole Blood Finger prick HBV card test kit for detection of HBsAg\nSpecification : \n1) The assay should be able to detect HBsAg by immunochromatographic assay or any other principle.\n2) Test should have a sensitivity of 99% -100% and a specificity of 99%-100%.\n3) The total test procedure up to the result will not exceed 30 minutes \n4) The packing should be in a manner enabling performance of a single test at a time.\n5) Storage of the test kits at room temperature should be possible upto 40 degrees celsius\n6) Pack size should be for 50 tests.\n7) Shelf Life- minimum 18 months from manufacture W04/KCR 48000 50 TESTS KIT with 20 ml Buffer solution and 50 lancets
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.

Copyright © 2021 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail